Phase II trial of gemcitabine and cisplatin/carboplatin (GC) plus erlotinib in patients with recurrent and/or metastatic nasopharyngeal cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2011
At a glance
- Drugs Carboplatin; Cisplatin; Erlotinib; Gemcitabine
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 14 Jul 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 14 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.